ACHE and Alzheimer disease: Currently, the primary treatment for AD, which only provides symptomatic relief, is a cholinergic replacement therapy, represented by four FDA-approved acetylcholinesterase (AChE) inhibitors, donepezil, galantamine and rivastigmine [3].